Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRSNASDAQ:OPGNNASDAQ:QIPTNASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$5.14+6.0%$3.62$1.53▼$9.20$285.08M2.46264,060 shs446,052 shsOPGNOpGen$4.88$4.79$0.53▼$5.25$49.13M-1.689,550 shs3,600 shsQIPTQuipt Home Medical$1.97+2.1%$1.95$1.35▼$4.07$83.85M0.56381,678 shs234,733 shsTOIOncology Institute$2.35+2.6%$2.73$0.13▼$3.50$204.35M0.131.05 million shs1.32 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies+5.98%+1.78%+20.94%+100.00%+31.46%OPGNOpGen0.00%0.00%+3.83%+51.55%+94.42%QIPTQuipt Home Medical+2.07%+6.49%+9.14%-13.60%-36.66%TOIOncology Institute+2.62%+0.43%-22.19%+94.21%+457.66%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies0.5284 of 5 stars1.00.00.00.01.65.00.0OPGNOpGenN/AN/AN/AN/AN/AN/AN/AN/AQIPTQuipt Home Medical2.4064 of 5 stars3.52.00.00.02.41.70.6TOIOncology Institute2.5656 of 5 stars3.55.00.00.01.11.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.75-27.04% DownsideOPGNOpGen 0.00N/AN/AN/AQIPTQuipt Home Medical 3.00Buy$2.8544.67% UpsideTOIOncology Institute 3.00Buy$7.00197.87% UpsideCurrent Analyst Ratings BreakdownLatest OPGN, AIRS, TOI, and QIPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.005/14/2025QIPTQuipt Home MedicalBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $4.005/13/2025QIPTQuipt Home MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$4.00 ➝ $1.703/31/2025AIRSAirSculpt TechnologiesLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $2.50(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$172.10M1.76$0.18 per share28.92$1.37 per share3.75OPGNOpGen$2.67M18.38N/AN/A($11.55) per share-0.42QIPTQuipt Home Medical$240.85M0.36$1.04 per share1.90$2.49 per share0.79TOIOncology Institute$393.41M0.53N/AN/A$0.05 per share47.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$8.25M-$0.30N/A∞N/A-9.95%-15.01%-5.85%8/8/2025 (Estimated)OPGNOpGen-$32.67MN/A0.00∞N/A-1,140.36%N/A-287.58%7/7/2025 (Estimated)QIPTQuipt Home Medical-$6.76M-$0.21N/AN/AN/A-3.66%-8.38%-3.63%8/13/2025 (Estimated)TOIOncology Institute-$64.66M-$0.70N/A∞N/A-15.38%-445.02%-34.13%8/12/2025 (Estimated)Latest OPGN, AIRS, TOI, and QIPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million5/12/2025Q2 2025QIPTQuipt Home Medical$0.02-$0.07-$0.09-$0.07$88.29 million$57.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AOPGNOpGenN/AN/AN/AN/AN/AQIPTQuipt Home MedicalN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.900.570.57OPGNOpGenN/A5.455.45QIPTQuipt Home Medical0.761.220.85TOIOncology Institute14.581.791.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%OPGNOpGen2.68%QIPTQuipt Home Medical42.85%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%OPGNOpGen43.80%QIPTQuipt Home Medical13.40%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24058.78 million13.77 millionOptionableOPGNOpGen10010.07 million4.70 millionNot OptionableQIPTQuipt Home Medical1,20043.44 million37.62 millionOptionableTOIOncology Institute66089.23 million81.65 millionNot OptionableOPGN, AIRS, TOI, and QIPT HeadlinesRecent News About These CompaniesTOI - The Oncology Institute Inc Sustainability - MorningstarJune 24 at 5:48 PM | morningstar.comApprovals for oncology procedures rise under Ayushman Bharat Arogya Karnataka schemeJune 10, 2025 | timesofindia.indiatimes.comThe Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in StockJune 10, 2025 | insidertrades.comJane Street Group LLC Has $39,000 Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)June 10, 2025 | marketbeat.comThe Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in StockJune 9, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 673,676 Shares of StockJune 9, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 1,976,137 Shares of StockJune 6, 2025 | insidertrades.comBrad Hively Sells 1,976,137 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) StockJune 5, 2025 | marketbeat.comThe Oncology Institute set to join the Russell 2000® and Russell 3000® IndexesJune 3, 2025 | globenewswire.comShort Interest in The Oncology Institute, Inc. (NASDAQ:TOI) Increases By 26.4%June 3, 2025 | marketbeat.comOncology Institute (NASDAQ:TOI) Trading Up 2.9% - Time to Buy?May 31, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 203,532 Shares of StockMay 23, 2025 | insidertrades.comOncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)May 16, 2025 | finance.yahoo.comOncology Institute Shares Rise After Higher 1Q RevenueMay 15, 2025 | marketwatch.comThe Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 GuidanceMay 15, 2025 | finanznachrichten.deTOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growthMay 15, 2025 | msn.comQ1 2025 Oncology Institute Inc Earnings CallMay 15, 2025 | finance.yahoo.comThe Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comThe Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical OfficerMay 14, 2025 | globenewswire.comTopicus.com Inc. Announces Election of Members of the Board of DirectorsMay 13, 2025 | globenewswire.comThe Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor ConferenceMay 13, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOPGN, AIRS, TOI, and QIPT Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$5.14 +0.29 (+5.98%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$5.14 +0.00 (+0.10%) As of 06/24/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.OpGen NASDAQ:OPGN$4.88 0.00 (0.00%) As of 06/24/2025 10:53 AM EasternOpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.Quipt Home Medical NASDAQ:QIPT$1.97 +0.04 (+2.07%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$1.92 -0.04 (-2.28%) As of 06/24/2025 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Oncology Institute NASDAQ:TOI$2.35 +0.06 (+2.62%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$2.36 +0.01 (+0.26%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
